Proteomics International Secures licence for oesophageal cancer biomarkers
Proteomics International Laboratories (PIQ) secures a worldwide licence for oesophageal cancer biomarkers
The licence agreement to...
Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
12.5 million shares will issued to sophisticated and professional...
